Partnervest Advisory Services LLC lowered its position in SPDR S&P Biotech (NYSEARCA:XBI) by 0.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,320 shares of the exchange traded fund’s stock after selling 21 shares during the period. Partnervest Advisory Services LLC’s holdings in SPDR S&P Biotech were worth $256,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the company. Russell Investments Group Ltd. increased its stake in shares of SPDR S&P Biotech by 61.7% in the second quarter. Russell Investments Group Ltd. now owns 49,141 shares of the exchange traded fund’s stock valued at $3,792,000 after buying an additional 18,746 shares during the period. Bray Capital Advisors increased its stake in shares of SPDR S&P Biotech by 120.3% in the second quarter. Bray Capital Advisors now owns 15,610 shares of the exchange traded fund’s stock valued at $1,205,000 after buying an additional 8,525 shares during the period. Boston Advisors LLC purchased a new stake in shares of SPDR S&P Biotech during the second quarter valued at about $213,000. Meridian Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech during the second quarter valued at about $432,000. Finally, FineMark National Bank & Trust increased its stake in shares of SPDR S&P Biotech by 7.4% in the second quarter. FineMark National Bank & Trust now owns 5,210 shares of the exchange traded fund’s stock valued at $402,000 after buying an additional 360 shares during the period.

Shares of SPDR S&P Biotech (NYSEARCA XBI) opened at 74.47 on Friday. SPDR S&P Biotech has a 12 month low of $53.15 and a 12 month high of $82.38. The firm has a 50-day moving average of $78.58 and a 200 day moving average of $71.46.

COPYRIGHT VIOLATION NOTICE: “SPDR S&P Biotech (NYSEARCA:XBI) Shares Sold by Partnervest Advisory Services LLC” was first published by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/11/spdr-sp-biotech-nysearcaxbi-shares-sold-by-partnervest-advisory-services-llc.html.

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with MarketBeat.com's FREE daily email newsletter.